RxDoctor Payments Data

Steve Roberson, APRN

Family · Natchez, MSNPI 1669668422

Payments from drug & device makers

$4,057in general payments, 2019–2025

Across 253 payments — averaging $16.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$650
  • Boehringer Ingelheim$457
  • Johnson & Johnson$423
  • AbbVie$357
  • Pfizer$315
  • GSK$314
  • plus $2K from 16 others

What the payments were for

  • Food & beverage$4,057100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,057 in reported general payments places this provider in the 90th percentile of 3,007 family providers in Mississippi.

See all family providers in Mississippi

Medicare billing

Part B allowed, 2024
$14,745
Medicare patients
97
Services billed
3,144

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide18$28,316
EliquisApixaban44$25,544
JardianceEmpagliflozin20$21,248
OxycontinOxycodone Hcl11$18,431
XareltoRivaroxaban12$9,924
Tresiba Flextouch U-200Insulin Degludec16$9,627
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen378$8,044
Lantus SolostarInsulin Glargine,hum.Rec.Anlog53$7,554
SymbicortBudesonide/Formoterol Fumarate23$7,287
FarxigaDapagliflozin Propanediol12$6,373
Albuterol Sulfate HfaAlbuterol Sulfate43$1,784
Atorvastatin Calcium242$1,622
Gabapentin156$1,565
Losartan Potassium150$1,560
Valsartan83$1,477

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$114$28,31618 claims
PfizerEliquis$315$25,54444 claims
Boehringer IngelheimJardiance$457$21,24820 claims
AstraZenecaSymbicort, Farxiga$88$13,66035 claims
Johnson & JohnsonXarelto$423$9,92412 claims
AbbVieSynthroid$357$1,41117 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,007 family providers in Mississippi.

Other family in Natchez

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →